These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20509837)

  • 1. Lipid-activated nuclear receptors and sepsis.
    de Lima-Salgado TM; Cruz LM; Souza HP
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):258-65. PubMed ID: 20509837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.
    Kidani Y; Bensinger SJ
    Immunol Rev; 2012 Sep; 249(1):72-83. PubMed ID: 22889216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptors bridge hepatic lipid metabolism and inflammation.
    Liu Y; Qiu DK; Ma X
    J Dig Dis; 2012 Feb; 13(2):69-74. PubMed ID: 22257474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation.
    Schmuth M; Moosbrugger-Martinz V; Blunder S; Dubrac S
    Biochim Biophys Acta; 2014 Mar; 1841(3):463-73. PubMed ID: 24315978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors.
    Hong C; Tontonoz P
    Curr Opin Genet Dev; 2008 Oct; 18(5):461-7. PubMed ID: 18782619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
    Chinetti-Gbaguidi G; Staels B
    Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
    Li AC; Glass CK
    J Lipid Res; 2004 Dec; 45(12):2161-73. PubMed ID: 15489539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARs and other nuclear receptors in inflammation.
    Rizzo G; Fiorucci S
    Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brief Discussion on Lipid Activated Nuclear Receptors and their Potential Role in Regulating Microglia in Age-Related Macular Degeneration (AMD).
    Choudhary M; Malek G
    Adv Exp Med Biol; 2016; 854():45-51. PubMed ID: 26427392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear receptors as drug targets for metabolic disease.
    Schulman IG
    Adv Drug Deliv Rev; 2010 Oct; 62(13):1307-15. PubMed ID: 20655343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
    Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
    Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.
    Barish GD
    J Nutr; 2006 Mar; 136(3):690-4. PubMed ID: 16484544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic switching of human skeletal muscle cells in vitro.
    Thoresen GH; Hessvik NP; Bakke SS; Aas V; Rustan AC
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):227-34. PubMed ID: 21549583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of metabolism and inflammation by lipid-activated nuclear receptors.
    Bensinger SJ; Tontonoz P
    Nature; 2008 Jul; 454(7203):470-7. PubMed ID: 18650918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
    Kiss M; Czimmerer Z; Nagy L
    J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology.
    Schmuth M; Jiang YJ; Dubrac S; Elias PM; Feingold KR
    J Lipid Res; 2008 Mar; 49(3):499-509. PubMed ID: 18182682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining weight: the Keystone Symposium on PPAR and LXR.
    Lehrke M; Pascual G; Glass CK; Lazar MA
    Genes Dev; 2005 Aug; 19(15):1737-42. PubMed ID: 16077002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological roles of liver X receptors in immune cells.
    Pascual-García M; Valledor AF
    Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):235-49. PubMed ID: 22696047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: relationship between absolute configuration and subtype selectivity.
    Motoshima K; Ishikawa M; Hashimoto Y; Sugita K
    Bioorg Med Chem; 2011 May; 19(10):3156-72. PubMed ID: 21514830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.